The performance of the A-share market was relatively stable this morning, with major stock indexes rising and falling.
The Hong Kong stock market rose sharply, among which the Hang Seng technology index rose sharply again, with an intraday increase of more than 4%.
On the A-share and Hong Kong stock markets, Zte Corporation(000063) midday announcement, on March 22, 2022 (US time), the company received the court's judgment and ruled not to revoke the probation of Zte Corporation(000063) without any penalty.
A shares performed stably pharmaceutical sector led the increase
Market data show that the main stock indexes of Shanghai and Shenzhen stock markets rose and fell slightly in the morning.
Defense industry led the rise Jiangxi Hongdu Aviation Industry Co.Ltd(600316) , Lihang technology rose by the limit, Avic Electromechanical Systems Co.Ltd(002013) , Gaona Aero Material Co.Ltd(300034) , etc.
The pharmaceutical and biological sectors were among the top gainers Zhejiang Xinguang Pharmaceutical Co.Ltd(300519) , Pharmablock Sciences (Nanjing) Inc(300725) , Gansu Longshenrongfa Pharmaceutical Industry Co.Ltd(300534) , Jinghua Pharmaceutical Group Co.Ltd(002349) , Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) , Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) and other stocks rose by more than 10%.
According to the recent research view of Wanlian securities, under the background of repeated epidemics in China and the high attention paid by the state from covid-19 detection to isolation to treatment, the listed companies related to covid-19 pneumonia industry chain benefit, including 1) IVD industry chain (manufacturers whose antigen detection products have been approved to be listed in China, manufacturers whose antigen detection products have been approved to be listed abroad (it is expected to be certified in China in the future) and IVD upstream raw material enterprises) 2) Covid-19 specific drug industry chain (covid-19 specific drug R & D enterprises, covid-19 specific drug commercialization enterprises, covid-19 specific drug upstream enterprises and covid-19 specific drug R & D outsourcing enterprises) and 3) covid-19 traditional Chinese medicine industry chain related to the treatment of pneumonia. At the same time, we should also pay attention to the risks of centralized purchase and price reduction, deterioration of competition pattern, and failure of R & D progress to meet expectations.
Communications, food and beverage sectors also led the increase.
two new shares broke on the first day
recent performance differentiation of new shares
Today, two new shares were listed, but both new shares broke in the session.
Among them, n first drug - u was once as low as 30.60 yuan, down 23.31% from the issue price, and the floating loss of new shares in the first signing was up to more than 4000 yuan. According to the prospectus, the company is a small molecule innovative pharmaceutical company in the clinical research stage. The R & D pipeline covers other important diseases such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, thyroid cancer, ovarian cancer, leukemia, and other important diseases such as type II diabetes. The company expects to achieve operating income of 0 yuan to 2 million yuan in 1-3 months in 2022, down from 1-3 months in 2021. It is mainly affected by the progress of cooperative drug development and other factors. With the increase of R & D investment, it is expected that the company will still be in a state of loss from January to March 2022, realizing the net profit attributable to the shareholders of the parent company of - 50 million yuan to - 30 million yuan, and the net profit attributable to the shareholders of the parent company of - 50 million yuan to - 30 million yuan after deducting non recurring profits and losses. The loss range has expanded compared with the same period of last year.
N Heshun was once as low as 49 yuan, down 13.57% from the issue price. According to the prospectus, the company is a high-tech enterprise focusing on the R & D, production and sales of differentiated and functional biaxially stretched polyester film (BOPET film). It can produce polyester film products of various specifications, models and different uses according to the differentiated needs of customers. Its main products include colored photoelectric base film, transparent film and other functional films.
In addition to the two new shares listed today, many new shares broke on the first day recently. At the same time, many new shares rose sharply on the first day of listing.
According to the reporter's statistics, since March, 28 new shares have been listed, of which 9 new shares broke on the first day of listing, and the remaining 19 new shares rose on the first day.
financial V with more than 4 million fans was prosecuted
According to the official account of the Supreme People's Procuratorate, "procuratorate daily Justice Network" revealed that recently, the procuratorate of Pudong New Area, Shanghai, filed a public prosecution against Xu on suspicion of false advertising, crime of helping network information crime and illegal business crime. Mr. Xu helped Mr. Chen to act as an agent for the option warehouse software, and used Mr. Xu's influence to attract fans to invest in the warehouse software, with a commission of about 20 yuan per order.
It is reported that Xu is Xu Xiaofeng, a private finance V with more than 4 million fans on a platform.
The procuratorial daily pointed out that Xu posted a document on the platform for publicity and promotion, and used no capital limit and no transaction restrictions as bait to drain fans to the sub warehouse software. Seeing that the benefits of the product are good, Xu also asked his team's employees to promote the product in the live broadcast room, and solicited customers to invest through his customer service personnel to participate in the option trading business and earn commissions from it. After audit, Xu involved 12 agency accounts, involving an amount of more than 16 million yuan and illegal income of more than 1.5 million yuan.
"This trading software is a sub warehouse software, which must be informal, because a similar sub warehouse system has been punished by the CSRC before." As a private placement manager, Xu has corresponding financial knowledge and knows that the use of the off-site sub warehouse system violates the national financial management regulations, but for the sake of interests, he still did not hesitate to "wave a knife" to his fans and cut up "leeks".
Illegal operation of securities and futures is not Xu's only means to make money. Xu explained, "an intermediary came to us to advertise these big V, which is basically diversion. They sent me the compiled content, and the short link inside is attached with a QR code." For such advertisements, Xu charged 20000 yuan to 30000 yuan each, and later rose to 50000 yuan.
But Xu is not interested in the authenticity of the advertisement. In March 2019, Xu received an advertisement for stock consultation and exchange. Soon, fans successively reported to Xu and the platform that the link was a fraud link, and Xu was banned for some time. But under the temptation of money, Xu's first thought is not to protect the rights and interests of fans, but how to exempt himself from responsibility. In June 2020, knowing that the new advertising link was the same as the previously reported fraud link, Xu only added reminders such as "don't make investment other than stocks" and "don't have capital transactions with other bank accounts" after the advertisement, and continued to publish the advertisement for many times, making an illegal profit of 390000 yuan. The link was later confirmed as the wechat QR code of the fraud Gang, and has been filed for investigation by the public security.
In addition to the above advertisements that have been verified as fraudulent links, Xu also released a number of other advertisements. "Recommend an old friend. He tracked two 5g concept strong bull stocks and shared them with his brothers. If necessary, add wechat." This is the idiom of Xu's advertising, but in fact, the so-called friends he advertised who are familiar with, know and have strong stock manipulation ability actually don't know, and haven't verified their identity and advertising content.
After receiving the money, he directly forwarded the edited copy of these intermediaries with one click. After audit, Xu made illegal profits of more than 190000 yuan by publishing false advertisements.
At present, Xu Xiaofeng's private placement products have also been fully liquidated.
Hong Kong technology stocks rose further
In the Hong Kong stock market, the whole market rebounded further.
The Hang Seng index returned above the 22000 point integer mark, with an intraday increase of more than 2%.
The most typical performance is also the Hang Seng technology index, which is concentrated in technology stocks and Internet stocks. Market data show that the intraday increase of Hang Seng technology index once expanded to more than 4%.
Blibli - SW rose more than 15% in the session, leading the rise of component stocks.
Reading group rose more than 10% in the session.
Kwai -W, Alibaba -SW and millet group -W rose more than 8%. Mingyuanyun, meituan-w and other stocks also rose sharply.
After the financial stability and Development Commission of the State Council held a special meeting to study the current economic situation and capital market problems, technology stocks and Internet stocks continued to pick up.
Recently, many large Internet stock companies and technology companies have continued to promote repurchase, which has further boosted investor confidence.
Just yesterday, Alibaba announced that it would increase the share repurchase scale from US $15 billion to US $25 billion. This is Alibaba's largest repurchase plan in history. The board of directors announced that the total authorized shares of Alibaba would increase from US $25 billion to US $15 billion in the future. The share repurchase plan announced this time is valid for two years until March 2024. As of March 18, 2022, according to the share repurchase plan announced earlier, the company has repurchased a total of 56.2 million American depositary shares, with a total amount of about US $9.2 billion.
Yesterday, the announcement of Xiaomi group showed that on March 22, 2022, the board of directors formally decided to exercise the above share repurchase authorization to repurchase shares in the open market from time to time with a maximum total amount of HK $10 billion. We will repurchase shares in accordance with the listing rules. Xiaomi group announced that the board of Directors believes that the share repurchase under the current situation can show that the company is full of confidence in its business outlook and prospects, and will eventually bring benefits to the company and create value for shareholders. The board of Directors believes that the existing financial resources of the company are sufficient to support share repurchase and maintain a sound financial position.
In addition, Tencent, Jingdong and other companies have also been promoting repurchase plans or repurchase since this year.
